“…In drug discovery process (Yoon et al, 2014), the imidazole and benzimidazole nucleus, respectively, are key pharmacophores, as they are frequently confronted in those drugs that depict a variety of pharmacological activities including antiulcer (Torres et al, 2015), antihypertensive (Zhu et al, 2016), antiviral (Pan et al, 2015), antifungal (Patel et al, 2012), anticancer (Akhtar et al, 2017), anthelmintic (Mavrova et al, 2006), antibacterial (Patel et al, 2012), cytotoxicity (Akhtar et al, 2017), antimicrobial (Patel et al, 2012), antiâinflammatory (Gaba et al, 2014), antitumor (Wu et al, 2016), histamineâH3 antagonist (Venable et al, 2005), antioxidant (Sam Daniel Prabu et al, 2019), gastro protective (Loriga et al, 1992), DNA binding (Zhang et al, 2016 ) , and Alzheimer disease (Gulcan et al, 2019). In these days, one of the most wellâknown yet critical metabolic disorder is diabetes mellitus (DM) affecting more than 400 million people (Khursheed et al, 2019), distinguished by inflated bloodâglucose levels along with variations in carbohydrate, lipid and protein metabolism (Shobana et al, 2009).…”